INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

GHGuardant Health, Inc.

CIK 0001576280

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells2 / 22
Max Insider Score49
Connections15with evidence

GH · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Oct 17, 2026Oct 19, 2026
traded Oct 17, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 8071 · Services-Medical Laboratories · Nov 4, 2026
  • ← Disclosed trade inevidence
    Jonathan L. JacksonPurchase disclosed 2026-10-19 · Oct 19, 2026
  • ← Insider ofevidence
    Eltoukhy HelmyDirector, Co-Chief Executive Officer · Aug 27, 2026
  • ← Lobbied forevidence
    IPOLICY SOLUTIONSLDA Q1 2026 first quarter · Medicare/Medicaid, MED · Aug 26, 2026
0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M
—
250 sh
Oct 15, 2026
Oct 19, 2026
traded Oct 15, 2026
+4d
SEC FORM 4

Evidence

0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$19K
116 sh
Oct 16, 2026Oct 19, 2026
traded Oct 16, 2026
+3dSEC FORM 4

Evidence

5
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Oct 17, 2026Oct 19, 2026
traded Oct 17, 2026
+2dSEC FORM 4

Evidence

28
Jonathan L. JacksonDJoint
GHGuardant Health, Inc.
Purchase
BUY$15K – $50KSep 28, 2026Oct 19, 2026
traded Sep 28, 2026
+21dHOUSE PTR

Evidence

0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
250 sh
Oct 15, 2026Oct 19, 2026
traded Oct 15, 2026
+4dSEC FORM 4

Evidence

13
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
3,324 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

5
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
1,668 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

5
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
1,340 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

5
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
1,340 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

13
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
1,701 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

5
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
3,324 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

15
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Tax withholding
F$755K
4,320 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

5
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
1,668 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

5
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Option exercise
M—
1,701 sh
Oct 1, 2026Oct 2, 2026
traded Oct 1, 2026
+1dSEC FORM 4

Evidence

5
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC FORM 4

Evidence

5
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Sep 17, 2026Sep 21, 2026
traded Sep 17, 2026
+4dSEC FORM 4

Evidence

0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
249 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC FORM 4

Evidence

0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
249 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC FORM 4

Evidence

8
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
116 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC FORM 4

Evidence

40
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.38M
7,738 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC FORM 4

Evidence

34
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$632K
4,000 sh
Sep 11, 2026Sep 14, 2026
traded Sep 11, 2026
+3dSEC FORM 4

Evidence

24
EH
Eltoukhy HelmyDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Other acquisition or disposition
J—
25.0K sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC FORM 4

Evidence

12
EH
Eltoukhy HelmyDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Gift
G—
30.0K sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC FORM 4

Evidence

12
EH
Eltoukhy HelmyDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Other acquisition or disposition
J—
25.0K sh
Aug 26, 2026Aug 27, 2026
traded Aug 26, 2026
+1dSEC FORM 4

Evidence

16
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Option exercise
M$401K
14.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

29
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$605K
3,704 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

32
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.63M
9,934 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

20
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Option exercise
M$650K
32.3K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

36
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$3.14M
19.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

36
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$2.20M
13.2K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

22
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Open-market sale
SELL$67K
400 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

2
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Option exercise
M—
32.3K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

14
MJ
Monroe Terilyn J.Chief People Officer
GHGuardant Health, Inc.
Option exercise
M—
14.0K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC FORM 4

Evidence

23
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M$3.91M
35.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

16
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M$800K
28.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

32
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.24M
7,365 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$2.96M
17.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

25
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$580K
3,463 sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
28.2K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

2
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Option exercise
M—
35.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

36
FC
Freeman ChrisChief Commercial Officer
GHGuardant Health, Inc.
Open-market sale
SELL$6.00M
35.4K sh
Aug 10, 2026Aug 11, 2026
traded Aug 10, 2026
+1dSEC FORM 4

Evidence

49
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market purchase
BUY$78K
600 sh
Jun 15, 2026Jun 30, 2026
traded Jun 15, 2026
+15dSEC FORM 4

Evidence

2
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M$467K
111.8K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

17
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$9.64M
64.0K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

40
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$79K
600 sh
Jun 10, 2026Jun 30, 2026
traded Jun 10, 2026
+20dSEC FORM 4

Evidence

17
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$8.00M
52.9K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

2
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M$598K
143.0K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

0
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
143.0K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

37
KK
Kalia KumudChief Information Officer
GHGuardant Health, Inc.
Open-market sale
SELL$79K
600 sh
Jun 15, 2026Jun 30, 2026
traded Jun 15, 2026
+15dSEC FORM 4

Evidence

20
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$10.68M
70.5K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

17
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$7.10M
46.7K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

17
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3.89M
25.8K sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

8
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$6,120
40 sh
Jun 29, 2026Jun 30, 2026
traded Jun 29, 2026
+1dSEC FORM 4

Evidence

4
TA
Talasaz AmirAliDirector, Co-Chief Executive Officer
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
111.8K sh
Jun 26, 2026Jun 30, 2026
traded Jun 26, 2026
+4dSEC FORM 4

Evidence

21
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$256K
1,951 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC FORM 4

Evidence

11
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
232 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

11
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Option exercise
M—
4,203 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

11
HM
Hidalgo Medina ManuelDirector
GHGuardant Health, Inc.
Grant or award
A—
2,711 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

11
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise
M—
4,203 sh
Jun 17, 2026Jun 22, 2026
traded Jun 17, 2026
+5dSEC FORM 4

Evidence

  • ← Lobbied forevidence
    DC STRATEGISTS LLCLDA 1TY 2026 first quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Insider ofevidence
    Monroe Terilyn J.Chief People Officer · Jan 9, 2026
  • ← Insider ofevidence
    Talasaz AmirAliDirector, Co-Chief Executive Officer · Dec 10, 2025
  • ← Insider ofevidence
    Kalia KumudChief Information Officer · Dec 10, 2025
  • ← Insider ofevidence
    Chudova DaryaChief Technology Officer · Dec 10, 2025
  • ← Insider ofevidence
    Freeman ChrisChief Commercial Officer · Dec 8, 2025
  • ← Insider ofevidence
    Bell Michael BrianChief Financial Officer · Dec 8, 2025
  • ← Insider ofevidence
    Tariq MusaDirector · Nov 17, 2025
  • ← Insider ofevidence
    Saia John G.Chief Legal Officer · Nov 10, 2025
  • ← Insider ofevidence
    Hidalgo Medina ManuelDirector · Nov 10, 2025

    • Lobbying

    $421K reported · de-duplicated
    2026 Q2 $180K in-house2026 Q1 $241K in-house
    • TODD STRATEGY GROUP$80K2026 Q2 · posted Aug 26, 2026 · Health issues
    • In-house report$180K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • In-house report$241K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • DC STRATEGISTS LLC—2026 Q1 · posted Aug 26, 2026 ·
    • IPOLICY SOLUTIONS$16K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, MED
    • IPOLICY SOLUTIONS$16K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • TODD STRATEGY GROUP$80K2026 Q1 · posted Aug 26, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.